{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:42:03Z","timestamp":1789879323929,"version":"4.0.1"},"reference-count":190,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dame Sheila Sherlock EASL"},{"name":"European Association"},{"name":"Dame Sheila Sherlock EASL"},{"DOI":"10.13039\/501100000384","name":"Higher Education Funding Council of England","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000384","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.autrev.2012.10.019","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T11:31:58Z","timestamp":1354275118000},"page":"580-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: Lessons to learn from ANCA vasculitis and pemphigus vulgaris"],"prefix":"10.1016","volume":"12","author":[{"given":"Athanasios","family":"Mavropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoklia","family":"Orfanidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Smyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Billinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini I.","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.10.019_bb0005","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nri3261","article-title":"Lighting the fires within: the cell biology of autoinflammatory diseases","volume":"12","author":"Park","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2010.07.015","article-title":"Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity","volume":"10","author":"Torres-Aguilar","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0015","doi-asserted-by":"crossref","unstructured":"Gatto M, Zen M, Ghirardello A, Bettio S, Bassi N, Iaccarino L, et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev Sep. 18 in press, http:\/\/dx.doi.org\/10.1016\/j.autrev.2012.09.003 [Electronic publication ahead of print, pii: S1568-9972(12)00213-3].","DOI":"10.1016\/j.autrev.2012.09.003"},{"key":"10.1016\/j.autrev.2012.10.019_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2012.07.018","article-title":"Autoinflammation and autoimmunity: bridging the divide","volume":"12","author":"Doria","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0025","doi-asserted-by":"crossref","first-page":"J71","DOI":"10.1016\/j.jaut.2011.12.007","article-title":"Sex gender and autoimmunity","volume":"38","author":"Shoenfeld","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0030","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","article-title":"The role of gender and organ specific autoimmunity","volume":"11","author":"Nussinovitch","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2010.09.010","article-title":"Do infections facilitate the emergence of systemic sclerosis?","volume":"10","author":"Grossman","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0040","unstructured":"Sinico RA, Meroni P. The kaleidoscopic manifestations of systemic vasculitis. Autoimmun Rev Aug. 16 in press [PMID:2298647]."},{"issue":"2","key":"10.1016\/j.autrev.2012.10.019_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.autrev.2012.05.003","article-title":"What is the key environmental trigger in type 1 diabetes \u2014 is it viruses, or wheat gluten, or both?","volume":"12","author":"Barbeau","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12016-011-8259-x","article-title":"Autoimmunity and environment: am I at risk?","volume":"42","author":"Smyk","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0055","doi-asserted-by":"crossref","first-page":"J156","DOI":"10.1016\/j.jaut.2011.11.003","article-title":"Twin studies in autoimmune disease: genetics, gender and environment","volume":"38","author":"Bogdanos","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.11.015","article-title":"Autoimmunity: from the mosaic to the kaleidoscope","volume":"30","author":"Blank","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0065","first-page":"1","article-title":"Autoimmunity: From the mosaic to the kaleidoscope. Proceedings of a symposium in honor of Professor Shoenfeld in Tel Aviv, Israel, February 10-11, 2008","volume":"30","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0070","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.10.019_bb0075","unstructured":"Carvalheiro H, da Silva JA, Souto-Carneiro MM. Potential roles for CD8(+) T cells in rheumatoid arthritis. Autoimmun Rev Jul. 25 in press [PMID:22841983]."},{"issue":"2","key":"10.1016\/j.autrev.2012.10.019_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.autrev.2011.08.011","article-title":"The role of T cell apoptosis in nervous system autoimmunity","volume":"12","author":"Comi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-082708-100732","article-title":"Translating molecular insights in autoimmunity into effective therapy","volume":"27","author":"Feldmann","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.autrev.2012.10.019_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2012.04.003","article-title":"beta2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?","volume":"12","author":"Matsuura","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2012.02.007","article-title":"CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte","volume":"11","author":"Mageed","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0105","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.10.019_bb0110","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","article-title":"p38 MAP-kinases pathway regulation, function and role in human diseases","volume":"1773","author":"Cuenda","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2012.10.019_bb0115","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.7914033","article-title":"A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells","volume":"265","author":"Han","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.10.019_bb0120","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(94)90277-1","article-title":"A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins","volume":"78","author":"Rouse","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.10.019_bb0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2164-11-144","article-title":"Whole genome analysis of p38 SAPK-mediated gene expression upon stress","volume":"11","author":"Ferreiro","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.autrev.2012.10.019_bb0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(94)90278-X","article-title":"Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27","volume":"78","author":"Freshney","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.10.019_bb0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","article-title":"A protein kinase involved in the regulation of inflammatory cytokine biosynthesis","volume":"372","author":"Lee","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.10.019_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(00)02084-6","article-title":"Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade","volume":"483","author":"Brook","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2012.10.019_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-61779-367-7_19","article-title":"Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases","volume":"806","author":"Mavropoulos","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0150","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/emboj\/17.10.2817","article-title":"Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway","volume":"17","author":"Rincon","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2012.10.019_bb0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1074\/jbc.274.1.264","article-title":"p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes","volume":"274","author":"Dean","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.v25.i2.10","article-title":"Th1 and Th2 lymphocytes in autoimmune disease","volume":"25","author":"Crane","year":"2005","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0165","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood-2011-02-336552","article-title":"Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis","volume":"118","author":"Noubade","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0170","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-3565(25)21307-6","article-title":"Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function","volume":"279","author":"Badger","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.autrev.2012.10.019_bb0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/bbrc.1999.1454","article-title":"Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase","volume":"263","author":"Kumar","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0180","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.4049\/jimmunol.162.7.4246","article-title":"Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages","volume":"162","author":"Hale","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0185","doi-asserted-by":"crossref","first-page":"23668","DOI":"10.1074\/jbc.272.38.23668","article-title":"Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase","volume":"272","author":"Wang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nsb949","article-title":"Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity","volume":"10","author":"Fitzgerald","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0162-3109(00)00206-X","article-title":"Inhibition of p38 MAP kinase as a therapeutic strategy","volume":"47","author":"Lee","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.autrev.2012.10.019_bb0200","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1021\/jm3008008","article-title":"Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyr imidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor","volume":"55","author":"Asano","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0205","doi-asserted-by":"crossref","first-page":"13229","DOI":"10.1074\/jbc.272.20.13229","article-title":"Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1\/S through a mechanism requiring p38\/RK","volume":"272","author":"Molnar","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0210","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.4161\/cc.6.20.4774","article-title":"p38alpha: a suppressor of cell proliferation and tumorigenesis","volume":"6","author":"Hui","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2012.10.019_bb0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood-2002-03-0744","article-title":"Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development","volume":"101","author":"Hsu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0220","doi-asserted-by":"crossref","first-page":"20608","DOI":"10.1074\/jbc.271.34.20608","article-title":"Cyclin D1 expression is regulated positively by the p42\/p44MAPK and negatively by the p38\/HOGMAPK pathway","volume":"271","author":"Lavoie","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0225","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/MCB.20.3.936-946.2000","article-title":"Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells","volume":"20","author":"Merritt","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0230","first-page":"421","article-title":"p38 MAP kinase inhibitors: many are made, but few are chosen","volume":"8","author":"Dominguez","year":"2005","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.autrev.2012.10.019_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2004.03.009","article-title":"The p38 MAP kinase pathway as a therapeutic target in inflammatory disease","volume":"4","author":"Saklatvala","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0240","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7839144","article-title":"Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms","volume":"267","author":"Derijard","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.10.019_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response","volume":"20","author":"Dong","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0250","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/sj.emboj.7600173","article-title":"GADD45beta\/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells","volume":"23","author":"Chi","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2012.10.019_bb0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/MCB.16.3.1247","article-title":"MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway","volume":"16","author":"Raingeaud","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0260","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1074\/jbc.271.23.13675","article-title":"A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3","volume":"271","author":"Moriguchi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0265","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1074\/jbc.273.3.1741","article-title":"Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6","volume":"273","author":"Enslen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0270","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/emboj\/18.7.1845","article-title":"Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice","volume":"18","author":"Lu","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2012.10.019_bb0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9440(10)63108-2","article-title":"Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis","volume":"164","author":"Chabaud-Riou","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0280","doi-asserted-by":"crossref","first-page":"26225","DOI":"10.1074\/jbc.M606800200","article-title":"Multiple activation mechanisms of p38alpha mitogen-activated protein kinase","volume":"281","author":"Kang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0285","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.4049\/jimmunol.174.7.4301","article-title":"Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes","volume":"174","author":"Inoue","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0290","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cellsig.2009.11.020","article-title":"Differential activation of p38MAPK isoforms by MKK6 and MKK3","volume":"22","author":"Remy","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.autrev.2012.10.019_bb0295","doi-asserted-by":"crossref","first-page":"e28406","DOI":"10.1371\/journal.pone.0028406","article-title":"Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC","volume":"6","author":"Galan-Moya","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2012.10.019_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-2187-3-15","article-title":"Gadd45 in stress signaling","volume":"3","author":"Liebermann","year":"2008","journal-title":"J Mol Signal"},{"key":"10.1016\/j.autrev.2012.10.019_bb0305","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.160.2.920","article-title":"Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42\/44 mitogen-activated protein kinases","volume":"160","author":"Foey","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0310","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.1074\/jbc.273.20.12378","article-title":"T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK\/JNK signaling pathways sensitive to cyclosporin A","volume":"273","author":"Matsuda","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar1905","article-title":"The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells","volume":"8","author":"Dodeller","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.10.019_bb0320","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2174\/156802608786264245","article-title":"Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006\u20132008","volume":"8","author":"Pettus","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0325","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tips.2007.04.008","article-title":"Novel strategies for inhibition of the p38 MAPK pathway","volume":"28","author":"Zhang","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2012.10.019_bb0330","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.4049\/jimmunol.176.8.4616","article-title":"Selective requirement of p38alpha MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses","volume":"176","author":"Berenson","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cimm.1998.1448","article-title":"A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production","volume":"192","author":"Koprak","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0340","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.4049\/jimmunol.165.4.1782","article-title":"Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity","volume":"165","author":"Trotta","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0345","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/1521-4141(200010)30:10<2791::AID-IMMU2791>3.0.CO;2-D","article-title":"Regulation of p38 mitogen-activated protein kinase during NK cell activation","volume":"30","author":"Chini","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0350","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2004-07-2782","article-title":"Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells","volume":"105","author":"Mavropoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0355","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood.V96.5.1844","article-title":"Importance of the MKK6\/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity","volume":"96","author":"Visconti","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0360","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production","volume":"2","author":"Yang","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0365","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(01)00141-8","article-title":"GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells","volume":"14","author":"Lu","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2012.10.019_bb0370","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1865","article-title":"The many paths to p38 mitogen-activated protein kinase activation in the immune system","volume":"6","author":"Ashwell","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0375","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ni1176","article-title":"The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway","volume":"6","author":"Salvador","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ni1177","article-title":"Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases","volume":"6","author":"Salvador","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0385","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1182\/blood-2011-01-333039","article-title":"Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation","volume":"118","author":"Jirmanova","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0390","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1128\/MCB.22.13.4544-4555.2002","article-title":"Regulation of MTK1\/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding","volume":"22","author":"Mita","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0395","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4161\/cc.4.9.2043","article-title":"Activating p38 MAPK: new tricks for an old kinase","volume":"4","author":"Mittelstadt","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2012.10.019_bb0400","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/MCB.23.11.3859-3871.2003","article-title":"Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a","volume":"23","author":"Bulavin","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0405","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/MCB.01435-06","article-title":"Activation of MTK1\/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain","volume":"27","author":"Miyake","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.autrev.2012.10.019_bb0410","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2008-04-153304","article-title":"Genetic disruption of p38{alpha} Tyr-323 phosphorylation prevents TCR-mediated p38{alpha} activation and impairs IFN-{gamma} production","volume":"113","author":"Jirmanova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2012.10.019_bb0415","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.1067289","article-title":"MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha","volume":"295","author":"Ge","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.autrev.2012.10.019_bb0420","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1093\/emboj\/cdg552","article-title":"Feedback control of the protein kinase TAK1 by SAPK2a\/p38alpha","volume":"22","author":"Cheung","year":"2003","journal-title":"EMBO J"},{"issue":"48","key":"10.1016\/j.autrev.2012.10.019_bb0425","doi-asserted-by":"crossref","first-page":"33080","DOI":"10.1074\/jbc.M807574200","article-title":"TAK1 binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling","volume":"283","author":"Inagaki","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0430","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1128\/MCB.24.16.6957-6966.2004","article-title":"Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation","volume":"24","author":"Ohkusu-Tsukada","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0435","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4049\/jimmunol.176.3.1431","article-title":"Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2","volume":"176","author":"Johansen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0440","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4049\/jimmunol.178.7.4153","article-title":"Gadd45alpha regulates p38-dependent dendritic cell cytokine production and Th1 differentiation","volume":"178","author":"Jirmanova","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0445","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(93)90383-2","article-title":"MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo","volume":"75","author":"Sun","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.10.019_bb0450","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1084\/jem.20051794","article-title":"MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock","volume":"203","author":"Zhao","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.10.019_bb0455","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1780005","article-title":"MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?","volume":"178","author":"Clark","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0460","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4049\/jimmunol.176.3.1899","article-title":"Essential role of MAPK phosphatase-1 in the negative control of innate immune responses","volume":"176","author":"Salojin","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0465","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.0510965103","article-title":"Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses","volume":"103","author":"Chi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.10.019_bb0470","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.20060336","article-title":"Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1","volume":"203","author":"Abraham","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.10.019_bb0475","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1128\/MCB.22.22.7802-7811.2002","article-title":"Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38","volume":"22","author":"Lasa","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0480","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.0701679104","article-title":"Molecular basis of MAPK-activated protein kinase 2:p38 assembly","volume":"104","author":"White","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.10.019_bb0485","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.270.45.27213","article-title":"Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif","volume":"270","author":"Engel","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0490","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/MCB.01456-06","article-title":"The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK","volume":"27","author":"Ronkina","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0495","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.177.3.1913","article-title":"MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis","volume":"177","author":"Hegen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/10061","article-title":"MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis","volume":"1","author":"Kotlyarov","year":"1999","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0505","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1074\/jbc.C100685200","article-title":"MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels","volume":"277","author":"Neininger","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0510","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.4049\/jimmunol.168.9.4667","article-title":"Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection","volume":"168","author":"Lehner","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0515","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1093\/emboj\/18.18.4969","article-title":"The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism","volume":"18","author":"Winzen","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2012.10.019_bb0520","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2012.10.019_bb0525","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/MCB.26.6.2408-2418.2006","article-title":"Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways","volume":"26","author":"Brook","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0530","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/MCB.22.13.4827-4835.2002","article-title":"Distinct cellular functions of MK2","volume":"22","author":"Kotlyarov","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0535","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14728222.12.8.921","article-title":"MK2: a novel molecular target for anti-inflammatory therapy","volume":"12","author":"Duraisamy","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.autrev.2012.10.019_bb0540","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bmcl.2007.12.037","article-title":"Pyrazinoindolone inhibitors of MAPKAP-K2","volume":"18","author":"Goldberg","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.autrev.2012.10.019_bb0545","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1016\/j.bmcl.2007.05.101","article-title":"The discovery of carboline analogs as potent MAPKAP-K2 inhibitors","volume":"17","author":"Wu","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.autrev.2012.10.019_bb0550","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jmb.2007.03.004","article-title":"Structural basis for a high affinity inhibitor bound to protein kinase MK2","volume":"369","author":"Hillig","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0555","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/ar432","article-title":"Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity","volume":"4","author":"Rosloniec","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.autrev.2012.10.019_bb0560","first-page":"1","article-title":"Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases","author":"Skurkovich","year":"2006","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.autrev.2012.10.019_bb0565","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","article-title":"How interferon-gamma keeps autoimmune diseases in check","volume":"29","author":"Kelchtermans","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0570","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2005.00252.x","article-title":"Interferons as pathogenic effectors in autoimmunity","volume":"204","author":"Baccala","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0575","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/154405910708600902","article-title":"p38 pathway kinases as anti-inflammatory drug targets","volume":"86","author":"Schindler","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.autrev.2012.10.019_bb0580","article-title":"The interaction between CXCL10 and cytokines in chronic inflammatory arthritis","author":"Lee","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0585","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.autrev.2012.02.019","article-title":"Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: Implication to clinical therapeutics","volume":"11","author":"Dong","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0590","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.autrev.2011.04.034","article-title":"Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?","volume":"10","author":"Costenbader","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0595","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI7317","article-title":"A proinflammatory role for IL-18 in rheumatoid arthritis","volume":"104","author":"Gracie","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.10.019_bb0600","first-page":"448","article-title":"Expression of interleukin 12 receptor (IL-12R) and IL-18R on CD4+ T cells from patients with rheumatoid arthritis","volume":"31","author":"Aita","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0605","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2007.074278","article-title":"The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis","volume":"67","author":"Schett","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.019_bb0610","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5","article-title":"Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis","volume":"46","author":"Brennan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.019_bb0615","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.bmcl.2004.03.106","article-title":"Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis","volume":"14","author":"Revesz","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.autrev.2012.10.019_bb0620","first-page":"488","article-title":"Potential of p38 inhibitors in the treatment of rheumatoid arthritis","volume":"13","author":"Foster","year":"2000","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.autrev.2012.10.019_bb0625","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/art.20580","article-title":"Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids","volume":"50","author":"Toh","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.10.019_bb0630","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/1568026054985911","article-title":"Potential adverse effects associated with inhibition of p38alpha\/beta MAP kinases","volume":"5","author":"Dambach","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0635","first-page":"1070","article-title":"VX-745. Vertex Pharmaceuticals","volume":"2","author":"Haddad","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.autrev.2012.10.019_bb0640","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1874312901206010209","article-title":"The p38 MAPK pathway in rheumatoid arthritis: a sideways look","volume":"6","author":"Clark","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.autrev.2012.10.019_bb0645","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","article-title":"Systemic lupus erythematosus one disease or many?","volume":"11","author":"Agmon-Levin","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0650","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2010.11.007","article-title":"Follicular helper T cells poise immune responses to the development of autoimmune pathology","volume":"10","author":"Gomez-Martin","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0655","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10875-009-9318-4","article-title":"Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus","volume":"29","author":"Wong","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0660","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.intimp.2011.04.015","article-title":"The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL\/lpr mouse model of systemic lupus","volume":"11","author":"Jin","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0665","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2012.10.019_bb0670","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0675","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"6","author":"Vergani","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.autrev.2012.10.019_bb0680","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2012.10.019_bb0685","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","article-title":"Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found","volume":"12","author":"Rigopoulou","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0690","doi-asserted-by":"crossref","first-page":"987471","DOI":"10.1155\/2012\/987471","article-title":"Epstein\u2013Barr virus as a trigger of autoimmune liver diseases","volume":"2012","author":"Rigopoulou","year":"2012","journal-title":"Adv Virol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0695","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2012.10.019_bb0700","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","article-title":"Susceptibility to thyroid disorders in hepatitis C","volume":"3","author":"Muratori","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0705","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0710","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0168-8278(03)00417-3","article-title":"Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity","volume":"39","author":"Bogdanos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0715","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","article-title":"Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection","volume":"133","author":"Gregorio","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0720","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0725","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0730","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1566524013363672","article-title":"Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity","volume":"1","author":"Wen","year":"2001","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.autrev.2012.10.019_bb0735","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.10.019_bb0740","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.autrev.2012.10.019_bb0745","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3748\/wjg.v13.i31.4249","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B","volume":"13","author":"Ma","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0750","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1016\/S0168-8278(10)61108-7","article-title":"Phosphorylation of p38 MAPK is detectable in NKT cells of patients with autoimmune hepatitis in whom it mirrors disease activity","volume":"52","author":"Mavropoulos","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0755","unstructured":"Holle JU, GrossWL. Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev Aug. 16 in press [PMID:22921792]."},{"key":"10.1016\/j.autrev.2012.10.019_bb0760","unstructured":"Sinico RA, Di Toma L, Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev Aug. 16 in press [PMID:22921791]."},{"key":"10.1016\/j.autrev.2012.10.019_bb0765","doi-asserted-by":"crossref","unstructured":"Radice A, Bianchi L, Sinico RA. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev Aug. 17 in press, http:\/\/dx.doi.org\/10.1016\/j.autrev.2012.08.008 [pii: S1568-9972(12)00172-3].","DOI":"10.1016\/j.autrev.2012.08.008"},{"key":"10.1016\/j.autrev.2012.10.019_bb0770","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.autrev.2011.11.007","article-title":"B-cell depleting agents for ANCA vasculitides: a new therapeutic approach","volume":"11","author":"Gomez-Puerta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0775","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autrev.2011.08.002","article-title":"Immune regulatory mechanisms in ANCA-associated vasculitides","volume":"11","author":"Lepse","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0780","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-012-0286-y","article-title":"Pathogenesis of ANCA-associated vasculitis","author":"Cartin-Ceba","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2012.10.019_bb0785","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOR.0b013e32834bde57","article-title":"Pathogenesis of ANCA-associated vasculitis: recent insights from animal models","volume":"24","author":"van Timmeren","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2012.10.019_bb0790","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2011.04362.x","article-title":"Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"164","author":"Savage","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0795","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12016-011-8258-y","article-title":"Pathogenesis of ANCA-associated vasculitis, an update","volume":"41","author":"Kallenberg","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0800","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.ASN.0000108520.63445.E0","article-title":"p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury","volume":"15","author":"Stambe","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0805","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.V12137","article-title":"Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies","volume":"12","author":"Kettritz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0810","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.ki.5000167","article-title":"IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis","volume":"69","author":"Hewins","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2012.10.019_bb0815","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.ASN.0000048715.12315.FD","article-title":"Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis","volume":"14","author":"Stambe","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0820","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1681\/ASN.2006010050","article-title":"Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6","volume":"18","author":"Sheryanna","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0825","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ard.2007.077263","article-title":"Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKalpha","volume":"67","author":"Polzer","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.019_bb0830","doi-asserted-by":"crossref","first-page":"e38317","DOI":"10.1371\/journal.pone.0038317","article-title":"p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation","volume":"7","author":"Hao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2012.10.019_bb0835","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/ard.2010.129106","article-title":"Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo","volume":"70","author":"van der Veen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.10.019_bb0840","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2249.2012.04616.x","article-title":"Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"169","author":"Coughlan","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0845","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2011.05.017","article-title":"Autoimmune blistering diseases of the skin","volume":"11","author":"Sticherling","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0850","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.autrev.2011.04.003","article-title":"Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature","volume":"10","author":"Sagi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0855","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.10.019_bb0860","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4049\/jimmunol.136.4.1227","article-title":"A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus","volume":"136","author":"Stanley","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0865","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ceb.2004.07.006","article-title":"Desmosomes and disease: pemphigus and bullous impetigo","volume":"16","author":"Payne","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0870","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-2230.2011.04092.x","article-title":"The pathogenic role of autoantibodies in pemphigus vulgaris","volume":"36","author":"Pan","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0875","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.autrev.2009.01.011","article-title":"Apoptosis in pemphigus","volume":"8","author":"Schmidt","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.10.019_bb0880","doi-asserted-by":"crossref","first-page":"23778","DOI":"10.1074\/jbc.M501365200","article-title":"Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization","volume":"280","author":"Berkowitz","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0885","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1073\/pnas.0602973103","article-title":"p38MAPK inhibition prevents disease in pemphigus vulgaris mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.10.019_bb0890","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2353\/ajpath.2008.080391","article-title":"Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin","volume":"173","author":"Berkowitz","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0895","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1074\/jbc.M111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0900","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1074\/jbc.M109.081570","article-title":"Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology","volume":"285","author":"Marchenko","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0905","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1478-3231.2006.01291.x","article-title":"Origin of cross-reactive autoimmunity in primary biliary cirrhosis","volume":"26","author":"Bogdanos","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2012.10.019_bb0910","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-008-8087-9","article-title":"Bacteria and primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0915","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/00365520410003236","article-title":"Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity","volume":"39","author":"Bogdanos","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2012.10.019_bb0920","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.20788","article-title":"Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic","volume":"42","author":"Bogdanos","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2012.10.019_bb0925","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaut.2004.03.002","article-title":"Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis","volume":"22","author":"Bogdanos","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2012.10.019_bb0930","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2012.10.019_bb0935","doi-asserted-by":"crossref","first-page":"37215","DOI":"10.1074\/jbc.M603622200","article-title":"MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27","volume":"281","author":"Zheng","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0940","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1021\/bi3007127","article-title":"Heat shock protein 27 mediated signaling in viral infection","volume":"51","author":"Rajaiya","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2012.10.019_bb0945","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1074\/jbc.M110.172874","article-title":"p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.10.019_bb0950","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.jid.5701080","article-title":"Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin","volume":"128","author":"Berkowitz","year":"2008","journal-title":"J Invest Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:32:28Z","timestamp":1745368348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212002777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":190,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1568997212002777"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.10.019","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: Lessons to learn from ANCA vasculitis and pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2012.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}